The National Institutes of Health on Monday discontinued a South African trial of an HIV vaccine regimen after data monitors concluded the treatment hadn't prevented new infections.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,